FIRST MANHATTAN CO. LLC. - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 40 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q2 2022$1,0000.0%5000.0%0.00%
Q1 2022$1,000
-50.0%
5000.0%0.00%
Q4 2021$2,000
+100.0%
5000.0%0.00%
Q3 2021$1,0000.0%5000.0%0.00%
Q2 2021$1,0000.0%5000.0%0.00%
Q1 2021$1,000
-50.0%
5000.0%0.00%
Q4 2020$2,000
-97.0%
500
-87.5%
0.00%
Q3 2020$67,000
+52.3%
4,0000.0%0.00%
Q2 2020$44,000
+144.4%
4,0000.0%0.00%
Q1 2020$18,000
+5.9%
4,0000.0%0.00%
Q4 2019$17,000
+13.3%
4,0000.0%0.00%
Q3 2019$15,000
+15.4%
4,000
+14.3%
0.00%
Q2 2019$13,000
-13.3%
3,5000.0%0.00%
Q1 2019$15,000
+25.0%
3,5000.0%0.00%
Q4 2018$12,000
-7.7%
3,5000.0%0.00%
Q3 2018$13,0000.0%3,5000.0%0.00%
Q2 2018$13,000
+18.2%
3,5000.0%0.00%
Q1 2018$11,000
-15.4%
3,5000.0%0.00%
Q4 2017$13,000
-7.1%
3,5000.0%0.00%
Q3 2017$14,0003,5000.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q2 2018
NameSharesValueWeighting ↓
ABNER HERRMAN & BROCK LLC 241,500$1,093,0000.17%
OCCUDO QUANTITATIVE STRATEGIES LP 90,584$410,0000.13%
EPIQ PARTNERS, LLC 10,550$48,0000.03%
Phoenix Holdings Ltd. 173,683$799,0000.02%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 5,500$25,0000.02%
CFO4Life Group, LLC 12,003$54,0000.02%
HighPoint Advisor Group LLC 15,733$115,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 357,761$1,619,0000.01%
Virtu Financial LLC 24,484$111,0000.01%
ETF MANAGERS GROUP, LLC 93,902$435,0000.01%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders